Advisor doctor and expert trainer, The National Center of Training and Development, Iraqi Ministry of Health, Baghdad, Iraq.
*Corresponding Author: Aamir Al-Mosawi, Advisor doctor and expert trainer, The National Center of Training and Development, Iraqi Ministry of Health, Baghdad, Iraq.
Citation: Aamir Al-Mosawi, (2023), The use of Coenzyme Q10 in Hypertension: An Educational Article and Expert Opinion, Clinical Research and Clinical Trials ;7(3): DOI :10.31579/2693-4779/128
Copyright: © 2023, Aamir Al-Mosawi,This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 06 April 2023 | Accepted: 16 April 2023 | Published: 23 April 2023
Keywords: Co-enzyme Q10; new hypertension treatment; expert opinion
Abstract
Dietary health supplements have been increasingly used in the prevention and treatment of chronic disorders. Coenzyme Q10 is a dietary health supplement that has been reported to have an anti-oxidant property as early as the 1966. The aim of this paper is to review coenzyme Q10 research findings relevant to its use in hypertension.
Introduction
Dietary health supplements have been increasingly used in the prevention and treatment of chronic disorders. [1-5]. Coenzyme Q10 is a dietary health supplement that has been reported to have an anti-oxidant property as early as the 1966. [6]. The aim of this paper is to review coenzyme Q10 research findings relevant to its use in hypertension.
In 1976, Yamagami and colleagues reported the treatment of five patients with primary hypertension associated with 20-40
Conclusion
The current evidence-base expert opinion suggests the coenzyme Q10 can used as anti-hypotensive agent in early hypertensive disease and in mild hypertension without significant irreversible vascular changes and also in isolated systolic hypertension.
Conflict Of Interest
References
- Al-Mosawi AJ. (2012). L-arginine research progress.1st ed., Saarbrücken; LAP Lambert Academic PublishinG.
View at Publisher |
View at Google Scholar
- Al-Mosawi AJ. (2021). The uses of L-Carnitine in cardiology. International Journal of Biomed Research,1(2): 1-5.
View at Publisher |
View at Google Scholar
- Al-Mosawi AJ. The use of L-Carnitine in Male Reproductive Abnormalities: The Available Evidence. International Journal of Clinical and Medical Education Research (ISSN: 2832-7705) 15 Nov 2022; 1(5): 150-152.
View at Publisher |
View at Google Scholar
- Al-Mosawi AJ. (2022). The use of cinnamon supplementation in diabetes: Research evidence and expert opinion. Journal of Clinical Trails and Bioavailability Research,1(1): 1-4.
View at Publisher |
View at Google Scholar
- Al-Mosawi AJ. (2022). The use of alpha-lipoic acid supplementation in diabetes: The available Evidence. Journal of Clinical Trails and Bioavailability Research,1(1): 1-6.
View at Publisher |
View at Google Scholar
- Mellors A, Tappel AL. (1996). Quinones and quinols as inhibitors of lipid peroxidation. Lipids,1(4):282-284.
View at Publisher |
View at Google Scholar
- Yamagami T, Shibata N, Folkers K. (1976). Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension. Res Commun Chem Pathol Pharmacol.14(4):721-727.
View at Publisher |
View at Google Scholar
- Digiesi V, Cantini F, Oradei A, Bisi G, Guarino GC, Brocchi A, Bellandi F, Mancini M, Littarru GP. (1994). Coenzyme Q10 in essential hypertension. Mol Aspects Med,257-263.
View at Publisher |
View at Google Scholar
- Langsjoen P, Langsjoen P, Willis R, Folkers K. (1994). Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med,265-272.
View at Publisher |
View at Google Scholar
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. (1999). Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens,13(3):203-208.
View at Publisher |
View at Google Scholar
- Burke BE, Neuenschwander R, Olson RD. (2001). Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J,94(11):1112-1117.
View at Publisher |
View at Google Scholar
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. (2007). Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens, 21(4):297-306.
View at Publisher |
View at Google Scholar